Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Hidding

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cephalalgia : an International Journal of Headache|October 27, 2010
Mere surgery will not cure cluster headache--implications for neurostimulationUte Hidding, Arne May
Journal of Neural Transmission (Vienna, Austria : 1996)|November 28, 2023
Therapeutic use of medical Cannabis in neurological diseases: a clinical updateUte Hidding, Tina Mainka, Carsten Buhmann
Journal of Parkinson'S Disease|November 20, 2020
Cannabis in Parkinson's Disease: The Patients' ViewFerhat Yenilmez, Odette Fründt, Ute Hidding, et al.
Fortschritte Der Neurologie-Psychiatrie|January 12, 2018
[Cannabis in Parkinson's Disease: Hype or help?]Tina Mainka, Jan Stork, Ute Hidding, et al.
Scientific Reports|July 15, 2017
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetryBirthe Stemplewitz, Robert Kromer, Eik Vettorazzi, et al.
Frontiers in Aging Neuroscience|September 26, 2025
Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaptionAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Journal of Neurology|June 8, 2026
Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patientsAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Plos One|August 16, 2016
Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence TomographyRobert Kromer, Carsten Buhmann, Ute Hidding, et al.
Biochemical Pharmacology|September 6, 2002
The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brainUte Hidding, Kirsten Mielke, Vicki Waetzig, et al.
Anatomical Record (Hoboken, N.J. : 2007)|September 4, 2009
FK506 protects against various immune responses and secondary degeneration following cerebral ischemiaStephan Brecht, Vicki Waetzig, Ute Hidding, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cephalalgia : an International Journal of Headache|October 27, 2010
Mere surgery will not cure cluster headache--implications for neurostimulationUte Hidding, Arne May
Journal of Neural Transmission (Vienna, Austria : 1996)|November 28, 2023
Therapeutic use of medical Cannabis in neurological diseases: a clinical updateUte Hidding, Tina Mainka, Carsten Buhmann
Journal of Parkinson'S Disease|November 20, 2020
Cannabis in Parkinson's Disease: The Patients' ViewFerhat Yenilmez, Odette Fründt, Ute Hidding, et al.
Fortschritte Der Neurologie-Psychiatrie|January 12, 2018
[Cannabis in Parkinson's Disease: Hype or help?]Tina Mainka, Jan Stork, Ute Hidding, et al.
Scientific Reports|July 15, 2017
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetryBirthe Stemplewitz, Robert Kromer, Eik Vettorazzi, et al.
Frontiers in Aging Neuroscience|September 26, 2025
Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaptionAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Journal of Neurology|June 8, 2026
Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patientsAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Plos One|August 16, 2016
Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence TomographyRobert Kromer, Carsten Buhmann, Ute Hidding, et al.
Biochemical Pharmacology|September 6, 2002
The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brainUte Hidding, Kirsten Mielke, Vicki Waetzig, et al.
Anatomical Record (Hoboken, N.J. : 2007)|September 4, 2009
FK506 protects against various immune responses and secondary degeneration following cerebral ischemiaStephan Brecht, Vicki Waetzig, Ute Hidding, et al.
Pageof 4